fda shortage list tirzepatide The Outsourcing Facilities Association (OFA) is suing the after the agency removed (Zepbound, Mounjaro) from the federal drug without proper notice. The lawsuit claims that the FDA failed The FDA has proposed to

Chad Janis launched a gummy bear supplement in August 2023 and sold it to Unilever this week for an estimated $1.2 billion

GLP-1 medications are increasingly prescribed off-label for weight management in non-diabetic adults

But for a patient with RA and obesity who isn't fully controlled, the metabolic-inflammatory axis is a lever I don't want to ignore

The new biosimilar drug could pose the first major challenge to Ozempic in China, where Novo Nordisks patent is set to expire in 2026.

Folks who scroll on TikTok may have come across videos from the 37-year-old social media

Keep your 3mL vials protected, organized, and ready to go with the Vial Vault 4-Vial Case